Amplia Therapeutics Limited (INNMF)
OTCMKTS · Delayed Price · Currency is USD
0.0890
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of $43.67 million as of February 12, 2026. Its market cap has increased by 117.12% in one year.
Market Cap
43.67M
Enterprise Value
23.26M
Revenue
3.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 30.82M to 43.67M, an increase of 41.72%. That is a compound annual growth rate of 2.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 43.82M | -14.63% |
| Dec 31, 2025 | 51.33M | 140.25% |
| Dec 31, 2024 | 21.37M | 101.06% |
| Dec 28, 2023 | 10.63M | 1.27% |
| Dec 29, 2022 | 10.49M | -54.88% |
| Dec 31, 2021 | 23.26M | 16.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 43.72M |
| ZIVO Bioscience | 40.17M |
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 31.12M |
| Oncotelic Therapeutics | 27.82M |